Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gemita Injection

Prescription Icon
Prescription Required

Marketer

Fresenius Kabi India Pvt Ltd

Salt Composition

Gemcitabine (1400mg) + Mannitol (36.8ml)

Overview Gemita Injection

Oncaspar injection is a prescription medication indicated for treating cancers of the lung (non-small cell), breast, pancreas, bladder, and ovaries. Its mechanism involves inhibiting cancer cell proliferation and promoting tumor regression. Administration must be overseen by a qualified healthcare provider; self-injection is strictly prohibited. Report any allergies to this medication to your physician immediately. Potential side effects include nausea, vomiting, alopecia, anemia (low red blood cell count), and leukopenia (low white blood cell count). Pre- and/or during-treatment blood tests may be required. Supplementation might be necessary to address medication-induced deficiencies. A diet rich in fruits and vegetables is also recommended. Disclose all other medications, pregnancy status, and existing health conditions to your doctor. This medication is contraindicated during breastfeeding. Alcohol consumption should be avoided. Refrain from driving or operating heavy machinery while undergoing treatment.

Uses of Gemita Injection

Malignant neoplasm

Major Benefits of Gemita Injection:

This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

Common Side effects of Gemita Injection:

  • Nausea
  • Vomiting
  • Diarrhea
  • Decreased blood cells (red cells, white cells, and platelets)
  • Rash
  • Increased liver enzymes
  • Blood in urine
  • Protein in urine
  • Breathlessness

How to use Gemita Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Gemita Injection works:

Gemita Injection merges gemcitabine and mannitol. Gemcitabine hinders cancer cell proliferation by disrupting DNA and RNA synthesis, effectively blocking their growth and reproduction. Mannitol, a pharmacologically inactive compound, possesses high osmotic properties, promoting diuresis by drawing fluid into the kidneys. Its additional uses include intraocular pressure reduction and cerebral edema management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Gemita Injection and alcohol may result in pronounced somnolence.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Gemita Injection during pregnancy is contraindicated due to established risks to fetal development. In exceptional circumstances involving life-threatening conditions, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingUNSAFE

Administering Gemita Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingUNSAFE

Administering Gemita Injection might reduce alertness, impair vision, or induce drowsiness and dizziness. Driving should be avoided if these effects manifest.

KidneyKidneySAFE IF PRESCRIBED

The use of Gemita Injection in patients with kidney impairment appears safe. Preliminary evidence indicates dose modification may be unnecessary, but physician consultation is advised.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding Gemita Injection's use in individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Gemita Injection :

NA

Facts to Know About Gemita Injection

LabelValue
Developing Habits No.
Treatment Category Cancer Medications
Gemita Injection
10,228
MRP 12,461
17% off